Fujian Haixi Pharmaceuticals Co., Ltd. (Stock code: 02637) submitted its Monthly Return for Equity Issuer for the period ended 30 November 2025. According to the announcement, the authorized/registered share capital stood at 78,707,270 shares, each with a par value of RMB 1, for a total of RMB 78,707,270.
Throughout November 2025, the issued share capital remained unchanged at 78,707,270 shares with no treasury shares reported. No share options, warrants, convertibles, or similar arrangements were disclosed. The submission was filed on 02 December 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments